Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma earnings on Wednesday, with investors focusing on ...

The downside risks of that bet have become clearer in recent days. Trump’s tendency to back off deadlines threatens to weaken ...

Immigration and Customs Enforcement has declared undocumented immigrants ineligible for bond hearings, thus opening the door ...

Last week, the Justice Department’s memo declaring that Epstein kept no “incriminating ‘client list’” led to widespread ...

The announcement comes as Trump has pushed through his tariff agenda by unveiling a new batch of letters to over 20 trade ...

European Union officials have drawn up plans to impose levies on American imports, but questions abound about whether they ...

The public split between Target and Twin Cities Pride, the nonprofit that throws the parade in Target's hometown, captures ...

President Donald Trump gave himself more time to reach trade deals with foreign nations, but his efforts to quickly overhaul ...

The president has earned a reputation for bluffing on tariffs. But he has steadily and dramatically raised U.S. tariffs, ...

As President Trump ramps up the pressure on dozens of countries, trade experts fear U.S. tariff policy leaves consumers and ...

The economy’s resilience so far to President Trump’s global trade war risks emboldening him and unleashing the sort of ...

Investors should ignore the daily back and forth on tariffs and focus instead on a handful of developments on the horizon.